S&C was named “Corporate/M&A Law Firm of the Year” at the Chambers USA 2024 Awards. The awards recognize a law firm’s preeminence in its practice areas and reflect achievements over the past 12 months, including outstanding work, impressive strategic growth and excellence in client service. S&C was also a finalist in the ‘Bankruptcy Law Firm of the Year’ category.
S&C’s M&A Group led all law firm advisers in announced and completed global deals in 2023, according to Bloomberg and LSEG, respectively. The Firm advised on global announced deals totaling more than $345 billion and on completed global deals totaling more than $431 billion.
In 2023, S&C advised on some of the most complex, high-value mergers of the year, including:
- Seagen’s $43 billion acquisition by Pfizer, the largest all-cash change-of-control pharma deal in history;
- Amgen’s $27.8 billion acquisition of Horizon Therapeutics, the largest announced healthcare merger in 2022;
- Enbridge’s $14 billion purchase of two utilities providers and a pending third provider, a deal that will create North America’s largest natural gas utility platform by volume;
- Credit Suisse’s $3.2 billion merger with UBS, the first combination of two global systemically banks;
- Cementos Argos’ $3.2 billion merger with Summit Materials, which created the fourth-largest cement platform in the United States;
- Subway’s milestone acquisition by Roark Capital, which will significantly expand the quick-service restaurant brand’s global presence; and
- C&S Wholesale Grocers’ $2.9 billion pending acquisition of hundreds of assets from The Kroger Company and Albertsons Companies, a deal that will strengthen the grocer’s supply chain solutions.